Dr. James Dunn, M.D

NPI: 1932140209
Total Payments
$53,152
2024 Payments
$82.07
Companies
7
Transactions
49
Medicare Patients
3,377
Medicare Billing
$379,154

Payment Breakdown by Category

Other$41,700 (78.5%)
Consulting$6,320 (11.9%)
Travel$4,150 (7.8%)
Food & Beverage$981.50 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $41,700 12 78.5%
Consulting Fee $6,320 3 11.9%
Travel and Lodging $4,150 18 7.8%
Food and Beverage $981.50 16 1.8%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $46,656 41 $0 (2024)
Regeneron Pharmaceuticals, Inc. $4,700 2 $0 (2023)
EyePoint Pharmaceuticals US, Inc. $1,620 1 $0 (2022)
Boston Scientific Corporation $120.93 2 $0 (2024)
Allergan Inc. $23.73 1 $0 (2017)
Shire North American Group Inc $15.56 1 $0 (2017)
Genentech USA, Inc. $15.39 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $82.07 2 Boston Scientific Corporation ($53.48)
2023 $4,767 3 Regeneron Pharmaceuticals, Inc. ($4,700)
2022 $1,620 1 EyePoint Pharmaceuticals US, Inc. ($1,620)
2018 $3,000 1 AbbVie, Inc. ($3,000)
2017 $43,682 42 AbbVie, Inc. ($43,628)

All Payment Transactions

49 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/05/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $53.48 General
Category: General - Pain Management_NMD
05/09/2024 ABBVIE INC. DURYSTA (Drug) Food and Beverage In-kind items and services $28.59 General
Category: EYE CARE
08/15/2023 Boston Scientific Corporation WaveWriter Alpha Prime 16 (Device) Food and Beverage In-kind items and services $67.45 General
Category: WaveWriter Alpha_NMD
06/09/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,820.00 General
06/09/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,880.00 General
04/01/2022 EyePoint Pharmaceuticals US, Inc. YUTIQ (Drug) Consulting Fee Cash or cash equivalent $1,620.00 General
Category: Chronic Non-infectious Posterior Segment Uveitis
10/09/2018 AbbVie, Inc. Humira (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: Immunology
10/13/2017 AbbVie, Inc. Humira (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,200.00 General
Category: Immunology
10/13/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $67.13 General
Category: Immunology
10/13/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $11.63 General
Category: Immunology
10/11/2017 AbbVie, Inc. Humira (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,200.00 General
Category: Immunology
10/11/2017 AbbVie, Inc. Humira (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,200.00 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $728.90 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $331.12 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $196.54 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $105.49 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $93.86 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $8.47 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $7.49 General
Category: Immunology
10/05/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $5.35 General
Category: Immunology
10/04/2017 AbbVie, Inc. Humira (Biological) Travel and Lodging In-kind items and services $331.11 General
Category: Immunology
07/24/2017 AbbVie, Inc. Humira (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,200.00 General
Category: Immunology
07/12/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $113.52 General
Category: Immunology
05/19/2017 Shire North American Group Inc XIIDRA (Drug) Food and Beverage In-kind items and services $15.56 General
Category: OPTHALMICS
05/04/2017 AbbVie, Inc. Humira (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,200.00 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 823 1,340 $286,480 $80,994
2022 11 932 4,228 $363,770 $108,151
2021 10 919 2,561 $369,725 $110,515
2020 10 703 2,233 $282,825 $79,494
Total Patients
3,377
Total Services
10,362
Medicare Billing
$379,154
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2023 213 272 $74,800 $25,176 33.7%
92012 Established patient problem focused exam of visual system Office 2023 171 335 $65,325 $21,298 32.6%
92134 Imaging of retina Office 2023 288 545 $79,025 $16,352 20.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 52 52 $18,460 $7,040 38.1%
67028 Injection of drug into eye Office 2023 31 47 $21,375 $4,524 21.2%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2023 25 36 $15,660 $3,850 24.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 22 $5,170 $1,894 36.6%
92250 Photography of the retina Office 2023 26 31 $6,665 $859.36 12.9%
92012 Established patient problem focused exam of visual system Office 2022 212 452 $88,090 $29,588 33.6%
92014 Established patient complete exam of visual system Office 2022 201 254 $69,850 $24,637 35.3%
92134 Imaging of retina Office 2022 281 586 $84,970 $18,360 21.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 73 73 $25,915 $10,233 39.5%
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg Office 2022 15 2,640 $16,500 $8,127 49.3%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2022 43 61 $26,535 $6,539 24.6%
67028 Injection of drug into eye Office 2022 30 62 $27,000 $6,104 22.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 21 $4,935 $1,540 31.2%
92250 Photography of the retina Office 2022 37 51 $10,965 $1,455 13.3%
J7999 Compounded drug, not otherwise classified Office 2022 12 14 $6,000 $1,004 16.7%
76512 2d ultrasound scan of eye tissue and structures Office 2022 11 14 $3,010 $564.97 18.8%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2021 226 510 $99,450 $35,457 35.7%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 178 206 $56,650 $21,318 37.6%
92134 Diagnostic imaging of retina Office 2021 253 558 $80,910 $18,783 23.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 73 73 $25,915 $9,720 37.5%
67028 Injection of drug into eye Office 2021 44 83 $36,375 $8,732 24.0%
92235 Imaging of blood vessels in back of eye using fluorescein dye Office 2021 57 69 $30,015 $7,148 23.8%

About Dr. James Dunn, M.D

Dr. James Dunn, M.D is a Ophthalmology healthcare provider based in Plymouth Meeting, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932140209.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Dunn, M.D has received a total of $53,152 in payments from pharmaceutical and medical device companies, with $82.07 received in 2024. These payments were reported across 49 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,700).

As a Medicare-enrolled provider, Dunn has provided services to 3,377 Medicare beneficiaries, totaling 10,362 services with total Medicare billing of $379,154. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Other Specialties Retina Specialist
  • Location Plymouth Meeting, PA
  • Active Since 06/09/2006
  • Last Updated 05/06/2019
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1932140209

Products in Payments

  • Humira (Biological) $46,628
  • YUTIQ (Drug) $1,620
  • WaveWriter Alpha Prime 16 (Device) $67.45
  • DURYSTA (Drug) $28.59
  • OZURDEX (Drug) $23.73
  • XIIDRA (Drug) $15.56
  • Lucentis (Biological) $15.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Plymouth Meeting